A phase II/III clinical study of thin ethyl etiopurpurin (Purlytin)- induced photodynamic therapy fort he treatment of recurrent cutaneous metastatic breast cancer. - Mang,TS.; Allison,R.; Hewson,G.; Snider,W.; Moskowitz,R.. (Cancer J Sci Am, 1998)